SCHEMBL25578922

SCHEMBL25578922

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2cccc(-c3cccc4ccccc34)c2)c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ DUSP3 P51452 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ MAPT P10636 4/20 0.32
▸ HPGD P15428 4/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.31
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25578952 0.95 MCL1 (0.34) MCL1ACMSDDUSP3AHRSCN5A
SCHEMBL25579471 0.94 CA12 (0.35) MCL1ACMSDDUSP3SCN5ASCN9A
SCHEMBL25580169 0.94 MCL1 (0.33) MCL1ACMSDDUSP3AHRCYP1A1
SCHEMBL25578930 0.94 MCL1 (0.34) MCL1ACMSDSCN5ASCN9AKDM4E
SCHEMBL25578687 0.94 CA12 (0.36) MCL1ACMSDDUSP3AHRSCN5A
SCHEMBL25580868 0.93 DUSP3 (0.33) MCL1ACMSDDUSP3AHRCYP1A1
SCHEMBL25580790 0.92 MCL1 (0.36) MCL1ACMSDDUSP3AHRCYP1A1
SCHEMBL23224568 0.91 MCL1 (0.36) MCL1ACMSDDUSP3AHRSCN5A
SCHEMBL25578787 0.91 AHR (0.35) AHRCYP1B1KDM4EALDH1A1MAPT
SCHEMBL24856488 0.91 AHR (0.36) AHRCYP1B1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 MCL1 3310/4885ACMSD 3888/4885DUSP3 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback